3/3
01:06 pm
femy
Femasys (FEMY) is now covered by Lake Street Capital. They set a "buy" rating and a $1.50 price target on the stock.
Low
Report
Femasys (FEMY) is now covered by Lake Street Capital. They set a "buy" rating and a $1.50 price target on the stock.
2/27
05:54 pm
femy
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
2/27
05:26 pm
femy
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/26
09:00 am
femy
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
Medium
Report
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
2/23
09:00 am
femy
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
Medium
Report
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
2/3
10:06 am
femy
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products [Yahoo! Finance]
Medium
Report
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products [Yahoo! Finance]
2/3
09:15 am
femy
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Low
Report
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
1/14
09:19 am
femy
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement [Yahoo! Finance]
High
Report
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement [Yahoo! Finance]
1/14
09:00 am
femy
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
High
Report
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
1/13
09:00 am
femy
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
Medium
Report
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
12/20
01:30 am
femy
Low
Report
12/18
09:15 am
femy
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
High
Report
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device